PreSERVE: A clinical research trial for adults post ST segment elevation myocardial infarction (STEMI).
This study will assess the safety and efficacy of intracoronary artery-administered stem cells taken from a patient's own bone marrow in patients who have had a recent myocardial infarction (heart attack).
You may be eligible for this study if you:
Are a male/female 18 years of age or older
Have had a recent myocardial infarction (within the past two to four days), treated successfully with stent or angioplasty
Have LVEF (left ventricular ejection fraction) of < 45 percent
You will be excluded from the study if you:
- Have severe cardiac valvular disease with plans to undergo surgery within one year
- Have AIDS or cirrhosis
This is a partial list of eligibility and exclusion criteria. To inquire whether you are eligible for this study, please call the contact number provided. If you choose to inquire via email, please refer to the study title in your correspondence.